Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1980959650;59651;59652 chr2:178592580;178592579;178592578chr2:179457307;179457306;179457305
N2AB1816854727;54728;54729 chr2:178592580;178592579;178592578chr2:179457307;179457306;179457305
N2A1724151946;51947;51948 chr2:178592580;178592579;178592578chr2:179457307;179457306;179457305
N2B1074432455;32456;32457 chr2:178592580;178592579;178592578chr2:179457307;179457306;179457305
Novex-11086932830;32831;32832 chr2:178592580;178592579;178592578chr2:179457307;179457306;179457305
Novex-21093633031;33032;33033 chr2:178592580;178592579;178592578chr2:179457307;179457306;179457305
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATC
  • RefSeq wild type template codon: TAG
  • Domain: Ig-119
  • Domain position: 20
  • Structural Position: 34
  • Q(SASA): 0.9483
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/V rs754507241 -0.05 None N 0.135 0.11 0.223146558224 gnomAD-2.1.1 8.05E-06 None None None None I None 0 0 None 0 0 None 0 None 0 1.78E-05 0
I/V rs754507241 -0.05 None N 0.135 0.11 0.223146558224 gnomAD-4.0.0 1.59192E-06 None None None None I None 0 0 None 0 0 None 0 0 2.85945E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.4113 ambiguous 0.2522 benign -0.545 Destabilizing 0.007 N 0.277 neutral None None None None I
I/C 0.7178 likely_pathogenic 0.6113 pathogenic -0.831 Destabilizing 0.356 N 0.505 neutral None None None None I
I/D 0.7906 likely_pathogenic 0.6494 pathogenic -0.138 Destabilizing 0.136 N 0.528 neutral None None None None I
I/E 0.6959 likely_pathogenic 0.5514 ambiguous -0.219 Destabilizing 0.136 N 0.538 neutral None None None None I
I/F 0.2442 likely_benign 0.1726 benign -0.548 Destabilizing 0.055 N 0.425 neutral N 0.48390016 None None I
I/G 0.6833 likely_pathogenic 0.491 ambiguous -0.683 Destabilizing None N 0.303 neutral None None None None I
I/H 0.611 likely_pathogenic 0.4712 ambiguous 0.053 Stabilizing 0.628 D 0.499 neutral None None None None I
I/K 0.5431 ambiguous 0.3861 ambiguous -0.392 Destabilizing 0.136 N 0.535 neutral None None None None I
I/L 0.1395 likely_benign 0.1137 benign -0.3 Destabilizing 0.005 N 0.197 neutral N 0.476915473 None None I
I/M 0.1244 likely_benign 0.0937 benign -0.561 Destabilizing 0.171 N 0.436 neutral N 0.508507816 None None I
I/N 0.3462 ambiguous 0.2288 benign -0.303 Destabilizing 0.106 N 0.555 neutral N 0.472104299 None None I
I/P 0.9158 likely_pathogenic 0.8894 pathogenic -0.351 Destabilizing 0.136 N 0.559 neutral None None None None I
I/Q 0.5484 ambiguous 0.3933 ambiguous -0.471 Destabilizing 0.628 D 0.529 neutral None None None None I
I/R 0.4723 ambiguous 0.3411 ambiguous 0.105 Stabilizing 0.356 N 0.547 neutral None None None None I
I/S 0.3782 ambiguous 0.2431 benign -0.732 Destabilizing 0.012 N 0.455 neutral N 0.451459668 None None I
I/T 0.2816 likely_benign 0.1588 benign -0.705 Destabilizing None N 0.184 neutral N 0.412015845 None None I
I/V 0.0685 likely_benign 0.0567 benign -0.351 Destabilizing None N 0.135 neutral N 0.443514975 None None I
I/W 0.8276 likely_pathogenic 0.7877 pathogenic -0.566 Destabilizing 0.864 D 0.504 neutral None None None None I
I/Y 0.5474 ambiguous 0.49 ambiguous -0.336 Destabilizing 0.356 N 0.533 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.